Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00178087 · ClinicalTrials.gov registry record

Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
331
Enrollment target

NCT00178087: Completed study, sponsored by University of Pittsburgh.

NCT00178087 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 331 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00178087 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
331 participants
Enrollment target

Study Summary

This study will determine the changes in brain structure and function that are responsible for mood and cognition changes that are sometimes associated with late-life depression.

Primary Outcome

Changes in z-scores of the language, visuospatial, attention, memory and executive cognitive domains

Trial Details

FieldValue
Enrollment Target 331 participants
Start Date 2005-08
Est. Completion 2011-08
University of Pittsburgh

1,238 total trials

What the finished NCT00178087 record still lists

NCT00178087 is an observational study that tracks outcomes without assigning an intervention. The registered 331 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00178087 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00178087 about?

NCT00178087 is a clinical study titled "Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression". This study will determine the changes in brain structure and function that are responsible for mood and cognition changes that are sometimes associated with late-life depression.

What is the current status of trial NCT00178087?

This trial is currently completed. The enrollment target is 331 participants. The study started on 2005-08. Estimated completion is 2011-08.

Who is sponsoring clinical trial NCT00178087?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174121 · 332 participants · Phase 2

    Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

  • NCT02605785 · 332 participants · NA

    A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

  • NCT04894006 · 332 participants · NA

    Dementia Family Caregiver Study

  • NCT05130606 · 332 participants · NA

    CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00178087, the US trial registry maintained by the National Library of Medicine. NCT00178087 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.